STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System
July 31, 2024
VANCOUVER, British Columbia -- STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel cell therapies to cure diseases. The CellPore™ Transfection System represents a substantial leap forward for cell engineering researchers, offering a novel method—known as mechanoporation—for cargo delivery [...]
bit.bio expands Executive Team with appointment of Przemek Obloj as Chief Financial Officer
July 31, 2024
Cambridge, UK – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with Founder and CEO, Mark Kotter, and the Executive Team [...]
July 31, 2024
MasterKey™ enhances accuracy with a database built from years of discovery proteomics, providing detailed protein insights, with new proteins added monthly. MasterKey™ enables researchers to customize protein selection from a vast database, selecting 50+ proteins for quantitative multiplex assays. MasterKey™ leverages advanced mass spectrometry and the validated InoKey™ workflow to ensure precision and reliability in [...]
Standard BioTools Announces Senior Leadership Changes
July 31, 2024
Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024 Industry Veteran Sean Mackay Named Chief Business Officer SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that Jeffrey Black, Chief Financial Officer, will resign [...]
July 31, 2024
SEATTLE -- TwinStrand Biosciences today announced an agreement with Exact Sciences (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, to exclusively license its patent estate in the cell free nucleic acid sequencing space, including its patent portfolios licensed from the University of Washington and the University of Texas Southwestern. The license is related to TwinStrand Duplex Sequencing® error-correction [...]
A PORTFOLIO COMPANY OF REYNOLDA EQUITY HAS ACQUIRED Tritech Field Engineering
July 31, 2024
Analytical Technologies Group ("ATG" or the "Company"), a portfolio company of Reynolda Equity Partners ("Reynolda"), has acquired Tritech Field Engineering ("Tritech"). Based in Providence, RI, ATG provides service, maintenance and repair for biopharmaceutical laboratory instruments utilized primarily in pharmaceutical, biotech and university laboratories. ATG services a variety of devices playing a c ritical role in [...]
Expanding the Dragonfly Series – Imaging Excellence and Modularity in High-end Confocal Microscopes
July 31, 2024
Oxford Instruments Andor, a world leader in scientific imaging solutions, today announces the launch of Dragonfly 400 and new VLE (Versatile Laser Engine), further expanding the award-winning Dragonfly confocal microscopy portfolio. The expansion of the range, which now comprises Dragonfly 200, 400 and 600, provides life science researchers and industry partners with tailored solutions that [...]
LumaCyte Launches Laser Force Cytology™ Academy after Training FDA Reviewers
July 30, 2024
CHARLOTTESVILLE, Va. -- LumaCyte, a trailblazer in advanced label-free cellular bioanalytical technology and instrumentation, proudly announces the launch of the Laser Force Cytology™ Academy—an interactive library of comprehensive training courses designed to deepen understanding of LumaCyte’s transformative Laser Force Cytology™ (LFC™) optical force technology. This new offering from LumaCyte aims to empower scientists and biomanufacturers [...]
Ansa Biotechnologies Pushes Limits of Complex DNA Synthesis with Launch of New Commercial Products
July 30, 2024
Only company able to offer ultra-rapid, assembly-free production of sequences up to 600 bp at scale in sequence-perfect clonal DNA or faster sequence-verified linear dsDNA fragment formats EMERYVILLE, Calif. -- Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced the commercial availability of its Ansa Clonal DNA and Ansa DNA Fragments. Ansa [...]
The New MagBinder® Fit24 Nucleic Acid Purification System Introduced at the 2024 ADLM in Chicago
July 30, 2024
Chicago, IL – Omega Bio-tek announces the release of the MagBinder® Fit24, its first piece of hardware for labs isolating DNA or RNA from various sample types for downstream analysis. This efficient, affordable instrument utilizes coordinated magnetic rods to pick up, transfer, and release magnetic particles within reagent cartridge wells, ensuring a reliable and streamlined [...]

